Thursday, Apr 25, 2024 | Last Update : 05:42 AM IST
Gilead
Health groups want India to rescind Gilead drug patents
Advocacy groups want remdesivir to be distributed more fairly to coronavirus patients around the world.
15 May 2020 11:46 AM
Gilead's three-drug HIV regimen wins European panel approval
Biktarvy is once-daily tablet combining emtricitabine, tenofovir alafenamide and integrase inhibitor bictegravir.
30 Apr 2018 9:57 AM
Gilead triple HIV drug finds US FDA approval
However, rival ViiV Healthcare, quickly filed a lawsuit alleging that Gilead was infringing patents on ViiV’s dolutegravir.
08 Feb 2018 9:54 AM
1 of 1
Columns
Senior IPS Officer Y. Puran Kumar Raises Eyebrows with Complaint of Car Discrimination Amid Lok Sabha Elections
Modi's "Guarantee 2024" vs Congress' "Nyay Patra" - A Clash of Narratives
Exploring the historical context and implications of the term "Hindu Rashtra" in light of constitutional and legal frameworks.
The BJP adapts its messaging, responding to opposition criticism with new assurances and clarifications.